421 related articles for article (PubMed ID: 11644906)
1. Trends in gene therapy regulation.
Lecomte V; Taylor A
Gene Ther; 1997 Feb; 4(2):77-8. PubMed ID: 11644906
[No Abstract] [Full Text] [Related]
2. Federal agency keeps review committee after public comments support continuation.
Maloney DM
Hum Res Rep; 1997 Jan; 12(1):1-2. PubMed ID: 11654603
[No Abstract] [Full Text] [Related]
3. Review panel cancels meeting as gene therapy proposals fall.
Wadman M
Nature; 1996 Feb; 379(6567):668. PubMed ID: 11644770
[No Abstract] [Full Text] [Related]
4. Special informed consent requirements are included in protocol review procedures.
Maloney DM
Hum Res Rep; 1995 Jul; 10(7):1-2. PubMed ID: 11654274
[No Abstract] [Full Text] [Related]
5. Fears mount for gene scrutiny as watchdog faces axe.
Kiernan V
New Sci; 1996 Jun; 150(2033):10. PubMed ID: 11656540
[No Abstract] [Full Text] [Related]
6. Beyond localism: a proposal for a National Research Review Board.
Levine C; Caplan AL
IRB; 1986; 8(2):7-9. PubMed ID: 11649751
[No Abstract] [Full Text] [Related]
7. Regulation of genetic modification of organisms: science or emotion?
Malinowski MJ
J Biolaw Bus; 1998; 1(3):3-7. PubMed ID: 11657280
[No Abstract] [Full Text] [Related]
8. International research agreement leads to new U.S. guidelines.
Maloney DM
Hum Res Rep; 1995 Apr; 10(4):1-2. PubMed ID: 11654182
[No Abstract] [Full Text] [Related]
9. Gene therapy panel gets a thumbs up.
Science; 1995 Nov; 270(5240):1287. PubMed ID: 11644754
[No Abstract] [Full Text] [Related]
10. NIH guidelines for research involving recombinant DNA molecules.
Wilson DJ
Account Res; 1993; 3(2-3):177-85. PubMed ID: 11652293
[No Abstract] [Full Text] [Related]
11. Regulation of human gene therapy in Australia.
Russel S
J Int Bioethique; 1991; 2(2):87-93. PubMed ID: 11659358
[No Abstract] [Full Text] [Related]
12. Proposal for a good clinical practice directive.
European Commission
Bull Med Ethics; 1998 Feb; No. 135():6-11. PubMed ID: 11657249
[No Abstract] [Full Text] [Related]
13. The federal policy for the protection of human subjects.
Porter JP
IRB; 1991; 13(5):8-9. PubMed ID: 11651250
[No Abstract] [Full Text] [Related]
14. IRBs and pharmaceutical company funding of research.
Jellinek MS; Levine RJ
IRB; 1982 Oct; 4(8):9-10. PubMed ID: 11651693
[No Abstract] [Full Text] [Related]
15. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) adopts Consolidated Guideline on Good Clinical Practice in the Conduct of Clinical Trials on Medicinal Products for Human Use.
Int Dig Health Legis; 1997; 48(2):231-4. PubMed ID: 11656783
[No Abstract] [Full Text] [Related]
16. Health Sciences Council of Japan adopts guidelines for gene therapy clinical research.
Int Dig Health Legis; 1995; 46(4):560-3. PubMed ID: 11657358
[No Abstract] [Full Text] [Related]
17. Much more research to fall under IRB review.
Maloney DM
Hum Res Rep; 1999 Jul; 14(7):3. PubMed ID: 11658059
[No Abstract] [Full Text] [Related]
18. The history of institutional review boards.
Sherman M; Van Vleet JD
Regul Aff J; 1991; 3():615-27. PubMed ID: 11651491
[No Abstract] [Full Text] [Related]
19. A regulatory overview of alternatives to animal testing: United States, Europe, and Japan.
Mayer FL; Whalen EA; Rheins LA
J Toxicol Cutaneous Ocul Toxicol; 1994; 13(1):3-22. PubMed ID: 11659896
[No Abstract] [Full Text] [Related]
20. Continuing review of research involving human subjects: approach to the problem and remaining areas of concern.
Gordon B; Prentice E
IRB; 1997; 19(2):8-11. PubMed ID: 11655323
[No Abstract] [Full Text] [Related]
[Next] [New Search]
